In this review:
This article is intended as an educational resource for healthcare professionals, particularly those in
the primary care clinical setting. The review presents relevant background information on the impact
of hyperglycaemia in persons with type 2 diabetes mellitus (T2DM) and focuses on pharmacologic
management strategies as recommended in New Zealand guidelines as well as those more recently
published by the American Diabetes Association (ADA) and the European Association for the Study of
Diabetes (EASD).
Download PDF